NVLN
Geode Capital Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-84,353
| Closed | -$61K | – | 4309 |
|
|
2019
Q3 | $61K | Sell |
84,353
-1,056
| -1% | -$764 | ﹤0.01% | 4042 |
|
|
2019
Q2 | $66K | Buy |
85,409
+528
| +0.6% | +$408 | ﹤0.01% | 4042 |
|
|
2019
Q1 | $104K | Buy |
84,881
+1,980
| +2% | +$2.43K | ﹤0.01% | 3888 |
|
|
2018
Q4 | $71K | Buy |
82,901
+26,003
| +46% | +$22.3K | ﹤0.01% | 3926 |
|
|
2018
Q3 | $168K | Buy |
56,898
+1,473
| +3% | +$4.35K | ﹤0.01% | 3802 |
|
|
2018
Q2 | $203K | Sell |
55,425
-29,086
| -34% | -$107K | ﹤0.01% | 3716 |
|
|
2018
Q1 | $295K | Buy |
84,511
+6,157
| +8% | +$21.5K | ﹤0.01% | 3574 |
|
|
2017
Q4 | $244K | Buy |
78,354
+40,194
| +105% | +$125K | ﹤0.01% | 3618 |
|
|
2017
Q3 | $268K | Buy |
38,160
+12,438
| +48% | +$87.4K | ﹤0.01% | 3571 |
|
|
2017
Q2 | $237K | Buy |
+25,722
| New | +$237K | ﹤0.01% | 3619 |
|